These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 34249090)

  • 1. Chloroquine and Sulfadoxine-Pyrimethamine Resistance in Sub-Saharan Africa-A Review.
    Roux AT; Maharaj L; Oyegoke O; Akoniyon OP; Adeleke MA; Maharaj R; Okpeku M
    Front Genet; 2021; 12():668574. PubMed ID: 34249090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
    Breman JG; Alilio MS; Mills A
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in malaria control in sub-Saharan Africa: the vaccine perspective.
    Lusingu JP; Von Seidlein L
    Tanzan J Health Res; 2008 Oct; 10(4):253-66. PubMed ID: 19402588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History and importance of antimalarial drug resistance.
    D'Alessandro U; Buttiëns H
    Trop Med Int Health; 2001 Nov; 6(11):845-8. PubMed ID: 11703837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
    Ogungbamigbe TO; Ojurongbe O; Ogunro PS; Okanlawon BM; Kolawole SO
    Mem Inst Oswaldo Cruz; 2008 Feb; 103(1):79-84. PubMed ID: 18368238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria.
    Menard D; Madji N; Manirakiza A; Djalle D; Koula MR; Talarmin A
    Am J Trop Med Hyg; 2005 May; 72(5):581-5. PubMed ID: 15940847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
    Mubyazi GM; Gonzalez-Block MA
    Malar J; 2005 Oct; 4():51. PubMed ID: 16242017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of malaria control in sub-Saharan Africa.
    Goodman CA; Coleman PG; Mills AJ
    Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial drug resistance in Africa: key lessons for the future.
    Takala-Harrison S; Laufer MK
    Ann N Y Acad Sci; 2015 Apr; 1342():62-7. PubMed ID: 25891142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
    Koram KA; Abuaku B; Duah N; Quashie N
    Acta Trop; 2005 Sep; 95(3):194-203. PubMed ID: 16054584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial.
    Kimani J; Phiri K; Kamiza S; Duparc S; Ayoub A; Rojo R; Robbins J; Orrico R; Vandenbroucke P
    PLoS One; 2016; 11(6):e0157045. PubMed ID: 27326859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large differences in prevalence of Pfcrt and Pfmdr1 mutations between Mwanza, Tanzania and Iganga, Uganda-a reflection of differences in policies regarding withdrawal of chloroquine?
    Kamugisha E; Bujila I; Lahdo M; Pello-Esso S; Minde M; Kongola G; Naiwumbwe H; Kiwuwa S; Kaddumukasa M; Kironde F; Swedberg G
    Acta Trop; 2012 Feb; 121(2):148-51. PubMed ID: 22118982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy.
    East African Network for Monitoring Antimalarial Treatment (EANMAT)
    Trop Med Int Health; 2003 Oct; 8(10):860-7. PubMed ID: 14516296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria.
    Müller O; van Hensbroek MB; Jaffar S; Drakeley C; Okorie C; Joof D; Pinder M; Greenwood B
    Trop Med Int Health; 1996 Feb; 1(1):124-32. PubMed ID: 8673817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
    Nsimba SE
    J Ethnobiol Ethnomed; 2006 Jan; 2():5. PubMed ID: 16403225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An economic comparison of chloroquine and sulfadoxine-pyrimethamine as first-line treatment for malaria in South Africa: development of a model for estimating recurrent direct costs.
    Wilkins JJ; Folb PI; Valentine N; Barnes KI
    Trans R Soc Trop Med Hyg; 2002; 96(1):85-90. PubMed ID: 11926003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfadoxine-pyrimethamine monotherapy in Tanzanian children gives rapid parasite clearance but slow fever clearance that is improved by chloroquine in combination therapy.
    Tarimo DS; Minjas JN; Bygbjerg IC
    Trop Med Int Health; 2002 Jul; 7(7):592-8. PubMed ID: 12100442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of maternal practices, efficacy, and cost-effectiveness of alternative antimalarial regimens for use in pregnancy: chloroquine and sulfadoxine-pyrimethamine.
    Schultz LJ; Steketee RW; Chitsulo L; Macheso A; Kazembe P; Wirima JJ
    Am J Trop Med Hyg; 1996; 55(1 Suppl):87-94. PubMed ID: 8702045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.